• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RADAR 剂量估算报告:基于 OLINDA/EXM 版本 2.0 的放射性药物剂量估算汇编。

RADAR Dose Estimate Report: A Compendium of Radiopharmaceutical Dose Estimates Based on OLINDA/EXM Version 2.0.

机构信息

Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, Tennessee; and

Nuclear Physics Enterprises, Marlton, New Jersey.

出版信息

J Nucl Med. 2018 Jan;59(1):154-160. doi: 10.2967/jnumed.117.196261. Epub 2017 Sep 8.

DOI:10.2967/jnumed.117.196261
PMID:28887400
Abstract

A compendium of about 100 radiopharmaceuticals, based on the OLINDA/EXM version 2.0 software, is presented. A new generation of voxel-based, realistic human computational phantoms developed by the RADAR committee of the Society of Nuclear Medicine and Molecular Imaging, based on 2007 recommendations of the International Commission on Radiological Protection, was used to develop the dose estimates, and the most recent biokinetic models were used as well. These estimates will be made available in electronic form and can be modified and updated as models are changed and as new radiopharmaceuticals are added.

摘要

本文呈现了基于 OLINDA/EXM 版本 2.0 软件的约 100 种放射性药物的概要。新一代基于体素的、真实的人体计算体模是由核医学与分子影像学会的 RADAR 委员会开发的,该体模基于国际放射防护委员会 2007 年的建议,用于开发剂量估算,并且还使用了最新的生物动力学模型。这些估算将以电子形式提供,并可以根据模型的变化和新放射性药物的添加进行修改和更新。

相似文献

1
RADAR Dose Estimate Report: A Compendium of Radiopharmaceutical Dose Estimates Based on OLINDA/EXM Version 2.0.RADAR 剂量估算报告:基于 OLINDA/EXM 版本 2.0 的放射性药物剂量估算汇编。
J Nucl Med. 2018 Jan;59(1):154-160. doi: 10.2967/jnumed.117.196261. Epub 2017 Sep 8.
2
MIRD Pamphlet No. 28, Part 2: Comparative Evaluation of MIRDcalc Dosimetry Software Across a Compendium of Diagnostic Radiopharmaceuticals.MIRD 手册第 28 号,第 2 部分:在一系列诊断放射性药物中比较 MIRDcalc 剂量计算软件的评估。
J Nucl Med. 2023 Aug;64(8):1295-1303. doi: 10.2967/jnumed.122.264230. Epub 2023 Jun 2.
3
New Fetal Dose Estimates from 18F-FDG Administered During Pregnancy: Standardization of Dose Calculations and Estimations with Voxel-Based Anthropomorphic Phantoms.妊娠期间 18F-FDG 给药的新胎儿剂量估算:基于体素的人体模型的剂量计算和估算标准化。
J Nucl Med. 2016 Nov;57(11):1760-1763. doi: 10.2967/jnumed.116.173294. Epub 2016 Jun 3.
4
NCINM: organ dose calculator for patients undergoing nuclear medicine procedures.NCINM:用于核医学程序患者的器官剂量计算器。
Biomed Phys Eng Express. 2020 Jul 20;6(5):055010. doi: 10.1088/2057-1976/aba41e.
5
Comparison of internal dose estimates obtained using organ-level, voxel S value, and Monte Carlo techniques.使用器官水平、体素S值和蒙特卡罗技术获得的内照射剂量估计值的比较。
Med Phys. 2014 Sep;41(9):092501. doi: 10.1118/1.4892606.
6
OLINDA/EXM 2-The Next-generation Personal Computer Software for Internal Dose Assessment in Nuclear Medicine.OLINDA/EXM 2——核医学内照射剂量评估的下一代个人计算机软件。
Health Phys. 2023 May 1;124(5):397-406. doi: 10.1097/HP.0000000000001682. Epub 2023 Feb 13.
7
OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine.OLINDA/EXM:用于核医学内照射剂量评估的第二代个人计算机软件。
J Nucl Med. 2005 Jun;46(6):1023-7.
8
Evaluation of absorbed and effective doses to patients from radiopharmaceuticals using the ICRP 110 reference computational phantoms and ICRP 103 formulation.使用国际放射防护委员会(ICRP)第110号参考计算体模和ICRP第103号公式评估放射性药物对患者的吸收剂量和有效剂量。
Radiat Prot Dosimetry. 2013 Sep;156(2):141-59. doi: 10.1093/rpd/nct049. Epub 2013 Mar 22.
9
Estimation of patient dose from radiopharmaceuticals using voxel models.使用体素模型估算放射性药物对患者的剂量。
Cancer Biother Radiopharm. 2005 Feb;20(1):103-9. doi: 10.1089/cbr.2005.20.103.
10
An internal radiation dosimetry computer program, IDAC 2.0, for estimation of patient doses from radiopharmaceuticals.一种用于估算放射性药物对患者剂量的体内辐射剂量学计算机程序IDAC 2.0。
Radiat Prot Dosimetry. 2014 Dec;162(3):299-305. doi: 10.1093/rpd/nct337. Epub 2013 Dec 18.

引用本文的文献

1
[F]MFBG PET/CT imaging of myocardial sympathetic innervation in healthy controls and patients with parkinson's disease: dosimetry and pharmacokinetics.[F]健康对照者和帕金森病患者心肌交感神经支配的MFBG PET/CT成像:剂量学与药代动力学
Eur J Nucl Med Mol Imaging. 2025 Sep 9. doi: 10.1007/s00259-025-07517-3.
2
S-values for bone marrow dosimetry in preclinical radiopharmaceutical studies with rodents.用于啮齿动物临床前放射性药物研究中骨髓剂量测定的S值。
EJNMMI Phys. 2025 Jul 8;12(1):67. doi: 10.1186/s40658-025-00752-5.
3
Personalized three-dimensional dose calculation method based on multi-modal images in dosimetry assessment of prostate cancer with skull metastasis: a Monte Carlo simulation study.
基于多模态图像的个性化三维剂量计算方法在前列腺癌伴颅骨转移剂量学评估中的应用:一项蒙特卡罗模拟研究
EJNMMI Phys. 2025 Jul 1;12(1):59. doi: 10.1186/s40658-025-00781-0.
4
IDAC-Dose 2.2, an internal dosimetry software for diagnostic nuclear medicine based on the latest ICRP adult and paediatric reference computational phantoms.IDAC-Dose 2.2,一款基于国际辐射防护委员会(ICRP)最新成人和儿童参考计算体模的诊断核医学内照射剂量软件。
EJNMMI Phys. 2025 Jun 13;12(1):56. doi: 10.1186/s40658-025-00774-z.
5
F-FDG PET/CT in Inflammation and Infection: Procedural Guideline by the Korean Society of Nuclear Medicine.18F-FDG PET/CT在炎症与感染中的应用:韩国核医学学会操作指南
Nucl Med Mol Imaging. 2025 Feb;59(1):27-40. doi: 10.1007/s13139-024-00894-x. Epub 2024 Dec 5.
6
First-in-human Evaluation of Safety and Dosimetry of [Cu]FBP8: A fibrin-binding PET Probe.[铜]FBP8(一种纤维蛋白结合PET探针)的人体首次安全性和剂量测定评估。
Mol Imaging Biol. 2025 Feb;27(1):99-108. doi: 10.1007/s11307-024-01973-3. Epub 2024 Dec 4.
7
First-in-human study of Tc-labeled fucoidan, a SPECT tracer targeting P-selectin.针对P-选择素的单光子发射计算机断层显像(SPECT)示踪剂锝标记岩藻多糖的首次人体研究。
EJNMMI Res. 2024 Nov 19;14(1):112. doi: 10.1186/s13550-024-01173-8.
8
Activity quantification and dosimetry in radiopharmaceutical therapy with reference to Lutetium.基于镥的放射性药物治疗中的活性定量与剂量测定
Front Nucl Med. 2024 Mar 28;4:1355912. doi: 10.3389/fnume.2024.1355912. eCollection 2024.
9
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma.用于胶质母细胞瘤靶向放射性核素治疗的CXCR4肽的临床前评估
EJNMMI Radiopharm Chem. 2024 Jul 15;9(1):52. doi: 10.1186/s41181-024-00282-y.
10
Dosimetry of [Cu]FBP8: a fibrin-binding PET probe.[铜]FBP8的剂量学:一种纤维蛋白结合PET探针。
medRxiv. 2024 Jun 28:2024.06.27.24309589. doi: 10.1101/2024.06.27.24309589.